Clinical Trial Update: Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) [Phase 3]

View source ↗

Summary

AFFIRM Phase 3 trial on rhythm management in atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Atrial Fibrillation

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Atrial Fibrillation | Phase 3 | Status: COMPLETED